September 17, 2022
Video

3-Year Outcomes from the Amplatzer™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial (Amulet IDE)

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected

    04:06

    C. Michael Gibson and Dhanunjaya Lakkireddy discuss the 3-year follow-up results of the AMULET IDE trial, including the reduced need for oral anticoagulants among patients.